World of DTC Marketing

DECEMBER 10, 2020

However, because of manufacturer discounts and rebates, the extent to which increases in wholesale list prices are associated with amounts paid by patients and insurers is poorly characterized. Pharma companies continue to be among the most profitable industries, even outperforming tech companies. The Pharma Spin.

Insurance 181

Insurance Pharma Manufacturing Retail 181

pharmaphorum

OCTOBER 26, 2022

When people think about pharma, they often think about “big” pharma: large, faceless corporations. The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We But rare diseases are a particularly important and challenging focus area. Chiesi’s philosophy in action.

Patients 96

Patients Pharma Consulting Transportation 96

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Essentially, both counterfeit and falsified medicines pose risks to public health and threaten to undermine the healthcare system and pharmaceutical industry.

Pharmaceutical 104

Pharmaceutical Medicine Manufacturing Pharmaceutical manufacturing 104

Impetus Digital

MARCH 14, 2023

Simplification In an increasingly complex healthcare system, it’s very easy to over-engineer a single aspect of health when in reality, what we need is a simplification of how we manage all aspects of our health. Before founding Redi.Health in 2021, Luke was the previous Director of Pharma Account Management at Cover My Meds.

Patients 100

Patients Management Medical Pharmaceutical manufacturing 100

European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Eversana Intouch

DECEMBER 13, 2024

We must ensure our messaging is tailored to apply and resonate across cultures, languages, regulations and healthcare systems. Correspondingly, pharmaceutical manufacturers spend exponentially more on marketing healthcare, including more than $6 billion annually on direct-to-consumer advertising.

Marketing 52

Marketing Manufacturing Healthcare Healthcare 52

Pharma Marketing Network

JANUARY 18, 2023

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Marketing Specialization Networking 52

PM360

SEPTEMBER 30, 2024

Sustainable Tech’s Positive Effect on Pharma Funding Recent innovations, including rapid advancements in AI-powered technologies and GLP-1s, have significantly impacted the investment climate and consolidated funding to a smaller number of organizations in the last eight months.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

European Pharmaceutical Review

DECEMBER 18, 2023

In 2023, the pharma industry has] witnessed tremendous advances in CAR T-cell immunotherapy of solid tumours” Another treatment modality that has witnessed significant advancement this year in the pharmaceutical industry, is cell and gene therapy. According to CPI, the facility is set to be completed in late 2025.

Manufacturing 98

Manufacturing Food and Drug Administration Medicine Pharmaceutical manufacturing 98

Prognos Health

MAY 31, 2023

Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Specialization Manufacturing Leads 52

Pharma Leaders

MAY 8, 2023

The Food and Drug Administration (FDA) has successfully inspected Nexus Pharmaceuticals’ pharmaceutical manufacturing facility located in Pleasant Prairie, Wisconsin, US. The inspection will allow the company to commence commercial operations at the three-storey, 84,000ft² manufacturing facility.

Manufacturing 52

Manufacturing Food and Drug Administration FDA Pharmaceutical manufacturing 52

PM360

AUGUST 9, 2022

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. Pharma Manufacturer Solutions. GM of Manufacturer Solutions. Furthermore, it is estimated to reach $6.5 billion in 2030 at a CAGR of 9.2%.

Prescription 105

Prescription Medical Patients Side effects 105

Pharmaceutical Technology

SEPTEMBER 13, 2022

On closing of the deal, the results of PharmaLex will be included as a component within the International Healthcare Solutions sector of AmerisourceBergen. The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Marketing 52

Impetus Digital

NOVEMBER 23, 2023

Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. The new way to engage KOLs at conferences: virtual Ambassador programs To start off the top-5, let’s take a look at how Pharma is shifting the way they engage key opinion leaders (KOLs) at medical congresses and conferences.

Education 52

Education Healthcare Provider Physicians Pharma 52

PM360

MAY 21, 2024

Pharmaceutical manufacturers know how important adherence to a treatment plan is and to help patients afford medications, manufacturer assistance programs are designed to make treatments more affordable. When treatments are missed or reduced, health outcomes suffer.

Electronics 52

Electronics Prescription Pharmaceutical manufacturing Patients 52

PM360

OCTOBER 22, 2024

Improving our collective understanding of the patient’s overall healthcare experience is necessary to effectively deliver prescription support. This is an achievable reality through strategic use of existing healthcare channels that have been negotiated for pharma access—inside the electronic health record (EHR).

Medical 52

Medical Patients Prescription Doctors 52

Pharmaceutical Technology

SEPTEMBER 15, 2022

The information contained within the download document is useful for pharmaceutical executives, drug development officers, product marketing managers, marketing executives, medical representatives, senior procurement executives, pharma packaging development specialists, and any other individual involved in pharmaceutical commercial packaging.

Leads 40

Leads Marketing Pharmaceutical Medicine 40

Pharmaceutical Technology

DECEMBER 19, 2022

Getting funding is going to be more difficult,” says Kyle Faget, partner and co-chair of Foley & Lardner’s Healthcare and Life Sciences Practices, Boston, Massachusetts. Pierre Socha, partner at Amadeus Capital Partners, London, UK, predicts that larger pharmaceutical companies may have similar interests.

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

PM360

AUGUST 26, 2024

Unlike the “un”targeted approaches that are often associated on the trial-and-error method, an expanded definition of precision medicine, with a smarter and more integrated tool set, will enable healthcare professionals (HCPs) to try the optimal therapeutic approach… the first time.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharma Marketing Network

JUNE 11, 2020

RJ Lewis (EHS): Hello, this is RJ Lewis and we’re back for Episode 2 with John Mack and Don Langsdorf, and we’re talking about the rebirth of Pharma Marketing and Pharma Guy. So, you continue with Pharma Marketing news. Where do you see it going? RJ Lewis (EHS): So, thanks for that question. That’s our vision.

Pharma 52

Pharma Marketing Media Healthcare 52

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

pharmaphorum

SEPTEMBER 30, 2022

This shift enables companies to improve the quality and compliance of the documents and data that make up regulatory submissions and create a data-sharing ecosystem that enhances healthcare. Over the years, pharmaceutical companies seeking product approvals have submitted increasingly vast amounts of information to regulatory agencies.

Management 52

Management Pharmaceutical Marketing Pharmaceutical manufacturing 52

Contrarian Sales Techniques

FEBRUARY 26, 2023

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% of gross domestic product (GDP). I also note that the five largest companies typically sell originator drugs and account for 47 percent of total drug imports.

Pharmaceutical 52

Pharmaceutical Medicine Government Manufacturing 52

pharmaphorum

JULY 28, 2022

Supply chain shortages have dominated headlines for several months, and the pharma industry has been no exception. The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceutical manufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems.

Pharma 111

Pharma FDA Consulting Manufacturing 111

Pharmaceutical Technology

JUNE 7, 2023

Fosun Pharma announced that the new facility will improve access to affordable life-saving drugs across west Africa and facilitate the transfer of medical and manufacturing knowledge to the African continent, supporting the long-term growth of the health sector in the region.

Manufacturing 96

Manufacturing Pharma Distribution Pharmaceutical products 96

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.

Pharmaceutical manufacturing 104

Pharmaceutical manufacturing Manufacturing Pharmaceutical Pharma 104

Medico Reach

FEBRUARY 8, 2023

The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. The global pharmaceutical manufacturing market stood at USD 405.52 The paradigm shift towards integrated, intelligent, and data-rich technologies is propelling the growth of medicines manufacturing. Let’s find out!

Pharma 52

Pharma Medicine Marketing Prospecting 52

pharmaphorum

AUGUST 4, 2022

Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks. For instance, in pharmaceutical manufacturing, mistakes in training can lead to contamination or waste, which can cause businesses unnecessary headaches.

Recruitment 98

Recruitment Training Pharma Pharmaceutical manufacturing 98

European Pharmaceutical Review

JUNE 6, 2023

Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainability, the certification will “promote responsible pharmaceutical manufacturing and help protect the natural environment and slow antimicrobial resistance”.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Pharmaceutical Pharma 98

PM360

NOVEMBER 14, 2023

In March of this year the three largest insulin manufacturers announced a dramatic reduction in the price of many commonly prescribed insulins and a monthly out-of-pocket (OOP) cap of $35 that went into effect in May. for only $35. “We References: 1.

Retail 52

Retail Sales Pharmaceutical manufacturing Insurance 52

Clarify Health

OCTOBER 26, 2021

In this blog, we take a close look at health equity in oncology trials specifically, assessing how the lack of diversity and inclusion has impacted cancer patients and the pharma industry’s key initiatives to address it. Clarify launched its real-world evidence on health disparities in 2021.

Food and Drug Administration 52

Food and Drug Administration Recruitment Pharmaceutical manufacturing Medical 52

World of DTC Marketing

APRIL 12, 2021

QUICK READ: Pharma supply chain issues are a concern for us all but especially patients. Hedley Rees has written a book on pharma supply chains that is eye-opening and downright scary. Can patients really be confident in pharma supply chains? Why would a pharma company take risks like these? Patients should be scared.

Food and Drug Administration 187

Food and Drug Administration Prescription Pharma Manufacturing 187

PM360

DECEMBER 20, 2023

Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. In 2021, the out-of-pocket (OOP) cost accounts for 28% of the whole healthcare expenses compared to 15.4% billion people in 2023).

Marketing 105

Marketing Insurance Medical Manufacturing 105

Pharmaceutical Technology

AUGUST 30, 2022

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

Manufacturing 78

Manufacturing Marketing Pharma Distribution 78

European Pharmaceutical Review

FEBRUARY 20, 2025

However, in the long term, increased costs could be passed on to healthcare systems, insurers, and ultimately, patients. 4 Reshoring and diversification of pharmaceutical supply chains In response to potential tariffs, pharmaceutical manufacturers could consider shifting production closer to domestic markets to reduce exposure.

Pharmaceutical 20

Pharmaceutical Manufacturing Medicine Pharmaceutical manufacturing 20

Clarivate

AUGUST 20, 2024

Pharmas may choose to accept these discounts as a standard business cost or revise their strategies to mitigate the risk of being selected for price negotiations. November’s elections could shape the future direction of drug price negotiations in the U.S.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52